Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Gisele Rocha Aguiar, Telma Leda Gomes de Lemos, Raimundo Braz-Filho, Aluísio Marques da Fonseca, Emmanuel Silva Marinho, Paulo Riceli Vasconcelos Ribeiro, Kirley Marques Canuto & Francisco José Queiroz Monte. (2023) Synthesis and in silico study of chenodeoxycholic acid and its analogues as an alternative inhibitor of spike glycoprotein of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 41:17, pages 8334-8348.
Read now
Read now
Gopalsamy Rajiv Gandhi, Chelankara Suresh Sharanya, Abhithaj Jayanandan, Madathilkovilakath Haridas, Varghese Edwin Hillary, Sathiyabama Rajiv Gandhi, Gurunagarajan Sridharan, Rengaraju Sivasubramanian, Alan Bruno Silva Vasconcelos, Monalisa Martins Montalvão, Stanislaus Antony Ceasar, Natália Ferreira de Sousa, Luciana Scotti, Marcus Tullius Scotti, Ricardo Queiroz Gurgel & Lucindo José Quintans-Júnior. (2023) Multitargeted molecular docking and dynamics simulation studies of flavonoids and volatile components from the peel of Citrus sinensis L. (Osbeck) against specific tumor protein markers. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-30.
Read now
Read now
J. Abhithaj, C. S. Sharanya, K. G. Arun, E. Jayadevi Variyar & C. Sadasivan. (2023) Trypsin is inhibited by phytocompounds liquiritin and terpinen-4-ol from the herb Glycyrrhiza glabra: in vitro and in silico studies. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-8.
Read now
Read now
Said Byadi, Domen Oblak, Yassine Kassmi, Karima Sadik, Mouhi Eddine Hachim, Črtomir Podlipnik & Aziz Aboulmouhajir. (2023) In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 41:7, pages 2900-2910.
Read now
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2022) Depicting the inhibitory potential of polyphenols from Isatis indigotica root against the main protease of SARS CoV-2 using computational approaches. Journal of Biomolecular Structure and Dynamics 40:9, pages 4110-4121.
Read now
Read now
Yasmine M. Mandour, Darius P. Zlotos & M. Alaraby Salem. (2022) A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease. Journal of Biomolecular Structure and Dynamics 40:5, pages 2327-2338.
Read now
Read now
Abhithaj J, Dileep Francis, Sharanya C.S.Arun K.G.Sadasivan C.E. Jayadevi Variyar. (2022) Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro. Journal of Biomolecular Structure and Dynamics 40:1, pages 325-336.
Read now
Read now
Rajesh Ghosh, Ayon Chakraborty, Ashis Biswas & Snehasis Chowdhuri. (2021) Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches. Journal of Biomolecular Structure and Dynamics 39:17, pages 6747-6760.
Read now
Read now
Articles from other publishers (33)
Hafiz Muzzammel Rehman, Muhammad Sajjad, Muhammad Akhtar Ali, Roquyya Gul, Muhammad Naveed, Muhammad Shahbaz Aslam, Khyber Shinwari, Munir Ahmad Bhinder, Muhammad Usman Ghani, Mahjabeen Saleem, Mohd Ashraf Rather, Ishtiyaq Ahmad & Adnan Amin. (2023) Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches. International Journal of Biological Macromolecules 237, pages 124169.
Crossref
Crossref
Hoshin Kim, Darin Hauner, Joseph A. Laureanti, Kruel Agustin, Simone Raugei & Neeraj Kumar. (2022) Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors. Scientific Reports 12:1.
Crossref
Crossref
Saeid Maghsoudi, Bahareh Taghavi Shahraki, Fatemeh Rameh, Masoomeh Nazarabi, Yousef Fatahi, Omid Akhavan, Mohammad Rabiee, Ebrahim Mostafavi, Eder C. Lima, Mohammad Reza Saeb & Navid Rabiee. (2022)
A review on computer‐aided chemogenomics and drug repositioning for rational
COVID
‐19 drug discovery
. Chemical Biology & Drug Design 100:5, pages 699-721.
Crossref
Crossref
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei & Awat Feizi. (2022) Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies. Canadian Journal of Infectious Diseases and Medical Microbiology 2022, pages 1-70.
Crossref
Crossref
Panagiotis Zagaliotis, Anthi Petrou, George Mystridis, Athina Geronikaki, Ioannis Vizirianakis & Thomas Walsh. (2022) Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. International Journal of Molecular Sciences 23:14, pages 8006.
Crossref
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Crossref
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino & Edeildo Ferreira da Silva-Júnior. (2022)
Repurposing FDA-approved Drugs Targeting SARS-CoV2 3CL
pro
: A
Study by Applying Virtual Screening, Molecular Dynamics, MM-PBSA
Calculations and Covalent Docking
. Letters in Drug Design & Discovery 19:7, pages 637-653.
Crossref
Crossref
Sumit Kumar, Svitlana Kovalenko, Shakshi Bhardwaj, Aaftaab Sethi, Nikolay Yu. Gorobets, Sergey M. Desenko, Poonam & Brijesh Rathi. (2022) Drug repurposing against SARS-CoV-2 using computational approaches. Drug Discovery Today 27:7, pages 2015-2027.
Crossref
Crossref
Kamonpan Sanachai, Tuanjai Somboon, Patcharin Wilasluck, Peerapon Deetanya, Peter Wolschann, Thierry Langer, Vannajan Sanghiran Lee, Kittikhun Wangkanont, Thanyada Rungrotmongkol & Supot Hannongbua. (2022) Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening. PLOS ONE 17:6, pages e0269563.
Crossref
Crossref
Mohamed Fadlalla, Mazin Ahmed, Musab Ali, Abdulrhman A. Elshiekh & Bashir A. Yousef. (2022) Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models. Current Pharmacology Reports 8:3, pages 212-226.
Crossref
Crossref
Sakshi Piplani, Puneet Singh, Nikolai Petrovsky & David A. Winkler. (2022) Computational Repurposing of Drugs and Natural Products Against SARS-CoV-2 Main Protease (Mpro) as Potential COVID-19 Therapies. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, Kamonpan Sanachai, Maliheh Ershadian & Chonlaphat Sukasem. (2022) Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies. Frontiers in Pharmacology 13.
Crossref
Crossref
Qiaoming Liu, Jun Wan & Guohua Wang. (2022) A survey on computational methods in discovering protein inhibitors of SARS-CoV-2. Briefings in Bioinformatics 23:1.
Crossref
Crossref
Amit Lochab, Rakhi Thareja, Sangeeta D. Gadre & Reena Saxena. (2021) Potential Protein and Enzyme Targets for In‐silico Development and Repurposing of Drug Against Coronaviruses. ChemistrySelect 6:46, pages 13363-13381.
Crossref
Crossref
Lianxiang Luo, Qin Qiu, Fangfang Huang, Kaifeng Liu, Yongqi Lan, Xiaoling Li, Yuge Huang, Liao Cui & Hui Luo. (2021) Drug repurposing against coronavirus disease 2019 (COVID-19): A review. Journal of Pharmaceutical Analysis 11:6, pages 683-690.
Crossref
Crossref
Souvik Banerjee, Shalini Yadav, Sourav Banerjee, Sayo O. Fakayode, Jyothi Parvathareddy, Walter Reichard, Surekha Surendranathan, Foyez Mahmud, Ryan Whatcott, Joshua Thammathong, Bernd Meibohm, Duane D. Miller, Colleen B. Jonsson & Kshatresh Dutta Dubey. (2021)
Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and
In Vitro
Study
. Journal of Chemical Information and Modeling 61:11, pages 5469-5483.
Crossref
Crossref
Merve Yuce, Erdem Cicek, Tugce Inan, Aslihan Basak Dag, Ozge Kurkcuoglu & Fethiye Aylin Sungur. (2021)
Repurposing of
FDA
‐approved drugs against active site and potential allosteric drug‐binding sites of
COVID
‐19 main protease
. Proteins: Structure, Function, and Bioinformatics 89:11, pages 1425-1441.
Crossref
Crossref
Avinash Kumar, Revathi Rajappan, Suvarna G. Kini, Ekta Rathi, Sriram Dharmarajan & K. Sreedhara Ranganath Pai. (2021) e-Pharmacophore model-guided design of potential DprE1 inhibitors: synthesis, in vitro antitubercular assay and molecular modelling studies. Chemical Papers 75:10, pages 5571-5585.
Crossref
Crossref
Anjela Manandhar, Vunnam Srinivasulu, Mohamad Hamad, Hamadeh Tarazi, Hany Omar, Dennis J. Colussi, John Gordon, Wayne Childers, Michael L. Klein, Taleb H. Al-Tel, Magid Abou-Gharbia & Khaled M. Elokely. (2021) Discovery of Novel Small-Molecule Inhibitors of SARS-CoV-2 Main Protease as Potential Leads for COVID-19 Treatment. Journal of Chemical Information and Modeling 61:9, pages 4745-4757.
Crossref
Crossref
Ali ACAR. (2021) Evaluation of phenolic acids of Corylus avellana L. as potential SARS CoV-2 Main protease inhibitorsPotansiyel SARS CoV-2 Ana proteaz inhibitörleri olarak Corylus avellana L.'nin fenolik asitlerinin değerlendirilmesi. Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi 14:2, pages 492-509.
Crossref
Crossref
Aditya K. Padhi, Soumya Lipsa Rath & Timir Tripathi. (2021) Accelerating COVID-19 Research Using Molecular Dynamics Simulation. The Journal of Physical Chemistry B 125:32, pages 9078-9091.
Crossref
Crossref
Kamran Waidha, Udi Zurgil, Efrat Ben-Zeev, Jacob Gopas, Saravanakumar Rajendran & Avi Golan-Goldhirsh. (2021) Inhibition of Cysteine Proteases by 6,6′-Dihydroxythiobinupharidine (DTBN) from Nuphar lutea. Molecules 26:16, pages 4743.
Crossref
Crossref
Shana V. Stoddard, Felissa E. Wallace, Serena D. Stoddard, Qianyi Cheng, Daniel Acosta, Shaliz Barzani, Marissa Bobay, Jared Briant, Christian Cisneros, Samantha Feinstein, Kelsey Glasper, Munazza Hussain, Abigail Lidoski, Pranay Lingareddy, Grace Lovett, Leslie Matherne, Jackson McIntosh, Nikita Moosani, Lia Nagge, Kudzai Nyamkondiwa, Isaiah Pratt, Emma Root, Mary Rose Rutledge, Mackenzie Sawyer, Yash Singh, Kristiana Smith, Ubaid Tanveer & Sona Vaghela. (2021) In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains. Biophysica 1:3, pages 311-327.
Crossref
Crossref
Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah & Khalid Mashay Al-Anazi. (2021) An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19. BioMed Research International 2021, pages 1-18.
Crossref
Crossref
Serena Dotolo, Anna Marabotti, Angelo Facchiano & Roberto Tagliaferri. (2021) A review on drug repurposing applicable to COVID-19. Briefings in Bioinformatics 22:2, pages 726-741.
Crossref
Crossref
Fangfang Yan & Feng Gao. (2021) An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2. Computational and Structural Biotechnology Journal 19, pages 4868-4883.
Crossref
Crossref
Sugandh Kumar, Bharati Singh, Pratima Kumari, Preethy V. Kumar, Geetanjali Agnihotri, Shaheerah Khan, Tushar Kant Beuria, Gulam Hussain Syed & Anshuman Dixit. (2021) Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity. Computational and Structural Biotechnology Journal 19, pages 1998-2017.
Crossref
Crossref
Pawan Kumar & Indira Ghosh. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses
179
202
.
Rajveer Singh, Anupam Gautam, Shivani Chandel, Arijit Ghosh, Dhritiman Dey, Syamal Roy, Velayutham Ravichandiran & Dipanjan Ghosh. (2020) Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study. Molecules 25:20, pages 4604.
Crossref
Crossref
Shana V. Stoddard, Serena D. Stoddard, Benjamin K. Oelkers, Kennedi Fitts, Kellen Whalum, Kaylah Whalum, Alexander D. Hemphill, Jithin Manikonda, Linda Michelle Martinez, Elizabeth G. Riley, Caroline M. Roof, Nowreen Sarwar, Doni M. Thomas, Emily Ulmer, Felissa E. Wallace, Pankaj Pandey & Sudeshna Roy. (2020) Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site. Viruses 12:9, pages 942.
Crossref
Crossref
Qingxin Li & CongBao Kang. (2020) Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease. Microorganisms 8:8, pages 1250.
Crossref
Crossref
Stefania Mazzini, Loana Musso, Sabrina Dallavalle & Roberto Artali. (2020) Putative SARS-CoV-2 Mpro Inhibitors from an In-House Library of Natural and Nature-Inspired Products: A Virtual Screening and Molecular Docking Study. Molecules 25:16, pages 3745.
Crossref
Crossref
Nilanjan Adhikari, Sk. Abdul Amin & Tarun Jha. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses
329
431
.